APA
Lee J. W., Alam J., Llewellyn N., Hurwitz S., Bubrick E. B., Sarkis R. A., Weisholtz D., Yu H., Putta S., Dworetzky B. A. & Pennell P. B. (20170119). Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. : Clinical neuropharmacology.
Chicago
Lee Jong Woo, Alam Javad, Llewellyn Nichelle, Hurwitz Shelley, Bubrick Ellen B, Sarkis Rani A, Weisholtz Daniel, Yu Hong, Putta Swapna, Dworetzky Barbara A and Pennell Page B. 20170119. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. : Clinical neuropharmacology.
Harvard
Lee J. W., Alam J., Llewellyn N., Hurwitz S., Bubrick E. B., Sarkis R. A., Weisholtz D., Yu H., Putta S., Dworetzky B. A. and Pennell P. B. (20170119). Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. : Clinical neuropharmacology.
MLA
Lee Jong Woo, Alam Javad, Llewellyn Nichelle, Hurwitz Shelley, Bubrick Ellen B, Sarkis Rani A, Weisholtz Daniel, Yu Hong, Putta Swapna, Dworetzky Barbara A and Pennell Page B. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. : Clinical neuropharmacology. 20170119.